EWMT ter Braak, AMMF Appelman, I van der … - Diabetes care, 2002 - Am Diabetes Assoc RESULTS—The increase in plasma glucagon with time from PG = 3.8 onward was
smaller for glyburide than for placebo (P = 0.014). Plasma glucagon area under
the curve (AUC) 60–180 was lower after glyburide than after placebo ... Cited by 13 - Related articles - BL Direct - All 6 versions
- ►endojournals.org L Landstedt-Hallin, U Adamson, PE Lins - Journal of Clinical Endocrinology & Metabolism, 1999 - Endocrine Soc Intensifying pharmacological therapy in patients with type 2 diabetes increases
the risk of hypoglycemia and often requires the simultaneous use of more than
one agent. Combining insulin and sulfonylurea is an effective and ... Cited by 30 - Related articles - BL Direct - All 5 versions
K Cejvan, DH Coy, JJ Holst, E Cerasi, S … - Diabetes, 2002 - Am Diabetes Assoc Arginine-stimulated insulin and somatostatin release is enhanced by the
sulfonylurea gliclazide. In contrast, gliclazide inhibits the glucagon response.
The aim of the present study was to investigate whether this inhibition of ... Cited by 10 - Related articles - BL Direct - All 5 versions
[CITATION] Sulphonylurea-induced hypoglycaemia in elderly people with diabetes
U Schweiger, W Greggersen, S Rudolf, M … - Psychosomatic Medicine, 2008 - pt.wkhealth.com Objective: To assess the whole-body glucose disposal in patients with both
typical and atypical depression and to characterize the neuroendocrine responses
during a hyper-, eu-, hypoglycemic stepwise clamp experiment in patients ... Cited by 2 - Related articles - BL Direct - All 5 versions
- ►endojournals.org SR Peacey, A Rostami-Hodjegan, E George, … - Journal of Clinical Endocrinology & Metabolism, 1997 - Endocrine Soc Disruption of intraislet mechanisms could account for the impaired glucagon
response to hypoglycemia in type 1 diabetes. However, in contrast to animals,
there is conflicting evidence that such mechanisms operate in humans. We ... Cited by 27 - Related articles - BL Direct - All 5 versions
SG Hartling, OK Faber, ML Wegmann, E … - Diabetes Care, 1987 - Am Diabetes Assoc The hypoglycemic effect of 2.5 mg glipizide and the potentiation of this effect
by ethanol were studied in 10 normal-weight nondiabetic subjects. The reductions
in blood glucose concentrations were similar in time of onset and extent (2 ... Cited by 11 - Related articles - All 4 versions
A Jönsson, JCN Chan, T Rydberg, S Vaaler, … - European journal of clinical pharmacology, 2000 - Springer Abstract Objective: We analysed the kinetics and e ects of glibenclamide (Gb) on
glucose, insulin and proinsulin secretion in two ethnic groups (10 in each) of
type-2 diabetic patients, one of Caucasian, the other of Chinese origin. ... Cited by 11 - Related articles - BL Direct - All 5 versions
Y Sako, T Wasada, F Umeda, H Ibayashi - Metabolism: clinical and experimental, 1986 - ncbi.nlm.nih.gov The effect of glibenclamide, a sulfonylurea agent, on islet hormone secretion,
particularly on glucagon was studied using isolated perifused pancreatic islets
of normal and cysteamine-treated rats. In normal rat islets, glibenclamide ... Cited by 12 - Related articles - All 2 versions
[CITATION] No reactive hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in …
